Back to
JANE STREET GROUP, LLC
BCTX1 quarters
Position history for
JANE STREET GROUP, LLC's holdings in BRIACELL THERAPEUTICS CORP
Yes. Jane Street Group holds 26,515 shares of BCTX (Briacell Therapeutics), worth $85,909, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$85,909
Current Shares
26,515
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of BCTX: UBS Group AG, CITADEL ADVISORS LLC, HRT FINANCIAL LP, MORGAN STANLEY